Apr 29, 2026 · 17m · top-founders

How Flossy Reached $4M ARR With AI Dental Receptionists

Miles Beckett · 11m spoken Nathan Latka · 4m spoken
0:00 / 0:00

gold bands on the timeline = statements, start to end. Hover to read, click to jump. CC turns on captions

In this interview with Nathan Latka, serial entrepreneur Miles Beckett breaks down how Flossy pivoted from a dental discount plan to an AI-powered voice receptionist, scaling to a $5 million ARR run rate through enterprise DSO sales.

How this conversation actually went

Every chapter scored 0–10 on four independent dynamics. Hover any point for the reasoning behind the score. Nathan holds 29.9% of the talking time here. How this is scored →

Nathan as informed peer 5.5 Guest teaching 4.7 Guest disagreement 1.5 Nathan pushing back 4.0
05100:0010:001:09–4:02 · Nathan as informed peer 5/10 The Origin of Flossy and AI Pivot Latka inquires into Flossy's origin story and pivot toward dental AI receptionists. When Beckett hedges on disclosing customer names, Latka pushes back to pin down specific location sizes.4:03–7:31 · Nathan as informed peer 5/10 Go-to-Market Evolution and Customer Expansion The conversation covers go-to-market motions and dental conference sales. Beckett educates Latka on why vertical-specific scheduling workflows outperform horizontal tools like Intercom.7:31–10:13 · Nathan as informed peer 4/10 Sponsor Break: FounderPath Capital for SaaS Founders Latka includes a sponsor segment for FounderPath before exploring Flossy's initial capitalization. Beckett walks through closing a $3M seed round right before COVID-19 lockdowns shut dental offices.10:13–12:33 · Nathan as informed peer 6/10 Venture Downturns and Historic Exit Negotiations Latka pushes Beckett on whether revenue collapsed after their Series A and questions how Beckett maintained M&A leverage while borrowing money from an acquirer. Beckett explains the strategic use of breakup fees.12:34–15:05 · Nathan as informed peer 7/10 SaaS Multiples and Navigating Company Restructuring Latka calculates Flossy's ARR run rate by combining disclosed location counts with $500 monthly ARPU. Beckett details previous workforce reductions and subsequent 60-70% month-over-month growth.15:06–16:50 · Nathan as informed peer 6/10 Analyzing the 2021 Venture Cohort and Valuation Realities Beckett shares perspectives on the unviable 2021 venture cohort valuations and the necessity of recapitalization. Latka tests Beckett's commitment by floating a hypothetical $40M cash buyout, which Beckett rejects.1:09–4:02 · Guest teaching 4/10 The Origin of Flossy and AI Pivot Latka inquires into Flossy's origin story and pivot toward dental AI receptionists. When Beckett hedges on disclosing customer names, Latka pushes back to pin down specific location sizes.4:03–7:31 · Guest teaching 5/10 Go-to-Market Evolution and Customer Expansion The conversation covers go-to-market motions and dental conference sales. Beckett educates Latka on why vertical-specific scheduling workflows outperform horizontal tools like Intercom.7:31–10:13 · Guest teaching 4/10 Sponsor Break: FounderPath Capital for SaaS Founders Latka includes a sponsor segment for FounderPath before exploring Flossy's initial capitalization. Beckett walks through closing a $3M seed round right before COVID-19 lockdowns shut dental offices.10:13–12:33 · Guest teaching 6/10 Venture Downturns and Historic Exit Negotiations Latka pushes Beckett on whether revenue collapsed after their Series A and questions how Beckett maintained M&A leverage while borrowing money from an acquirer. Beckett explains the strategic use of breakup fees.12:34–15:05 · Guest teaching 4/10 SaaS Multiples and Navigating Company Restructuring Latka calculates Flossy's ARR run rate by combining disclosed location counts with $500 monthly ARPU. Beckett details previous workforce reductions and subsequent 60-70% month-over-month growth.15:06–16:50 · Guest teaching 5/10 Analyzing the 2021 Venture Cohort and Valuation Realities Beckett shares perspectives on the unviable 2021 venture cohort valuations and the necessity of recapitalization. Latka tests Beckett's commitment by floating a hypothetical $40M cash buyout, which Beckett rejects.1:09–4:02 · Guest disagreement 2/10 The Origin of Flossy and AI Pivot Latka inquires into Flossy's origin story and pivot toward dental AI receptionists. When Beckett hedges on disclosing customer names, Latka pushes back to pin down specific location sizes.4:03–7:31 · Guest disagreement 1/10 Go-to-Market Evolution and Customer Expansion The conversation covers go-to-market motions and dental conference sales. Beckett educates Latka on why vertical-specific scheduling workflows outperform horizontal tools like Intercom.7:31–10:13 · Guest disagreement 1/10 Sponsor Break: FounderPath Capital for SaaS Founders Latka includes a sponsor segment for FounderPath before exploring Flossy's initial capitalization. Beckett walks through closing a $3M seed round right before COVID-19 lockdowns shut dental offices.10:13–12:33 · Guest disagreement 2/10 Venture Downturns and Historic Exit Negotiations Latka pushes Beckett on whether revenue collapsed after their Series A and questions how Beckett maintained M&A leverage while borrowing money from an acquirer. Beckett explains the strategic use of breakup fees.12:34–15:05 · Guest disagreement 1/10 SaaS Multiples and Navigating Company Restructuring Latka calculates Flossy's ARR run rate by combining disclosed location counts with $500 monthly ARPU. Beckett details previous workforce reductions and subsequent 60-70% month-over-month growth.15:06–16:50 · Guest disagreement 2/10 Analyzing the 2021 Venture Cohort and Valuation Realities Beckett shares perspectives on the unviable 2021 venture cohort valuations and the necessity of recapitalization. Latka tests Beckett's commitment by floating a hypothetical $40M cash buyout, which Beckett rejects.1:09–4:02 · Nathan pushing back 5/10 The Origin of Flossy and AI Pivot Latka inquires into Flossy's origin story and pivot toward dental AI receptionists. When Beckett hedges on disclosing customer names, Latka pushes back to pin down specific location sizes.4:03–7:31 · Nathan pushing back 3/10 Go-to-Market Evolution and Customer Expansion The conversation covers go-to-market motions and dental conference sales. Beckett educates Latka on why vertical-specific scheduling workflows outperform horizontal tools like Intercom.7:31–10:13 · Nathan pushing back 2/10 Sponsor Break: FounderPath Capital for SaaS Founders Latka includes a sponsor segment for FounderPath before exploring Flossy's initial capitalization. Beckett walks through closing a $3M seed round right before COVID-19 lockdowns shut dental offices.10:13–12:33 · Nathan pushing back 6/10 Venture Downturns and Historic Exit Negotiations Latka pushes Beckett on whether revenue collapsed after their Series A and questions how Beckett maintained M&A leverage while borrowing money from an acquirer. Beckett explains the strategic use of breakup fees.12:34–15:05 · Nathan pushing back 4/10 SaaS Multiples and Navigating Company Restructuring Latka calculates Flossy's ARR run rate by combining disclosed location counts with $500 monthly ARPU. Beckett details previous workforce reductions and subsequent 60-70% month-over-month growth.15:06–16:50 · Nathan pushing back 4/10 Analyzing the 2021 Venture Cohort and Valuation Realities Beckett shares perspectives on the unviable 2021 venture cohort valuations and the necessity of recapitalization. Latka tests Beckett's commitment by floating a hypothetical $40M cash buyout, which Beckett rejects.

speaking balance: gold is Nathan, purple is the guest (3 minute bins)

0:00 · Nathan 46.3% · guest 53.7%0:00 · Nathan 46.3% · guest 53.7%3:00 · Nathan 34.3% · guest 65.7%3:00 · Nathan 34.3% · guest 65.7%6:00 · Nathan 22.4% · guest 77.6%6:00 · Nathan 22.4% · guest 77.6%9:00 · Nathan 16.3% · guest 83.7%9:00 · Nathan 16.3% · guest 83.7%12:00 · Nathan 22.3% · guest 77.7%12:00 · Nathan 22.3% · guest 77.7%15:00 · Nathan 39.4% · guest 60.6%15:00 · Nathan 39.4% · guest 60.6%
Sharpest disagreement ▶ 10:27 Beckett rejects the premise of revenue collapse

Beckett flatly disagrees with Latka's suggestion that their revenue crashed, arguing that market-wide VC corrections and tight cash runways are standard venture dynamics.

Hardest push from Nathan ▶ 3:35 Latka demands scale metrics after customer evasion

When Beckett deflects naming enterprise clients, Latka interrupts to reframe the question strictly around location counts rather than confidential brand names.

Biggest teaching moment ▶ 11:07 Beckett breaks down breakup fee mechanics in distressed M&A

Beckett explains to Latka how negotiating a $1M breakup fee allowed his startup to borrow bridge capital from its buyer without sacrificing transaction valuation.

Nathan holds their own ▶ 13:56 Latka synthesizes location data into run rate estimates

Latka demonstrates sharp financial modeling by multiplying disclosed customer tiers by the $500 monthly price point to accurately predict Flossy's $4M run rate.

the scores for every segment, with the reasoning behind each
ChapterTopicNathan as informed peerGuest teachingGuest disagreementNathan pushing backWhy
The Origin of Flossy and AI Pivot 5425 Latka inquires into Flossy's origin story and pivot toward dental AI receptionists. When Beckett hedges on disclosing customer names, Latka pushes back to pin down specific location sizes.
Go-to-Market Evolution and Customer Expansion 5513 The conversation covers go-to-market motions and dental conference sales. Beckett educates Latka on why vertical-specific scheduling workflows outperform horizontal tools like Intercom.
Sponsor Break: FounderPath Capital for SaaS Founders 4412 Latka includes a sponsor segment for FounderPath before exploring Flossy's initial capitalization. Beckett walks through closing a $3M seed round right before COVID-19 lockdowns shut dental offices.
Venture Downturns and Historic Exit Negotiations 6626 Latka pushes Beckett on whether revenue collapsed after their Series A and questions how Beckett maintained M&A leverage while borrowing money from an acquirer. Beckett explains the strategic use of breakup fees.
SaaS Multiples and Navigating Company Restructuring 7414 Latka calculates Flossy's ARR run rate by combining disclosed location counts with $500 monthly ARPU. Beckett details previous workforce reductions and subsequent 60-70% month-over-month growth.
Analyzing the 2021 Venture Cohort and Valuation Realities 6524 Beckett shares perspectives on the unviable 2021 venture cohort valuations and the necessity of recapitalization. Latka tests Beckett's commitment by floating a hypothetical $40M cash buyout, which Beckett rejects.

Statements from this episode (20)

Opinion
Beckett: Dental Insurance Is Not Worth It Financially
“Dental insurance is really not worth it when you look at the numbers.”
Miles Beckett Apr 29, 2026 ▶ 1:52
Disclosure
Flossy built its AI receptionist to replace internal call agents
“And then we started building this AI receptionist with the idea that we could replace some of the call agents that we were using on our team, and that's what really set us down the path.”
Miles Beckett Apr 29, 2026 ▶ 2:28
Disclosure
Flossy charges roughly $500 per location monthly for AI receptionists
“It's about 500 bucks a month per location. That can go up or down depending upon usage.”
Miles Beckett Apr 29, 2026 ▶ 2:44
Disclosure
Flossy signs multiple enterprise DSOs with over 100 locations each
“So, you know, we've signed, you know, multiple, you know, hundred location plus DSOs that are then doing, like, varying degrees of roll-out, sometimes in chunks, sometimes location by location.”
Miles Beckett Apr 29, 2026 ▶ 3:07
Assertion Not checkable as stated
Beckett: Flossy serves at least 300 to 500 dental brand customers
“Yeah, higher than yeah, probably at least three to 500, maybe more.”
Miles Beckett Apr 29, 2026 ▶ 5:24
Assertion Supported
Flossy raised a $3M seed round at the start of COVID-19
“So we raised a seed round for the original business in Right when the pandemic hit, we actually closed on the financing. We actually didn't do anything with the money, so we went the, like, literally, four or five million, or? It was, like, three million.”
Miles Beckett Apr 29, 2026 ▶ 8:23
Disclosure
Beckett: Flossy was originally conceived as a full dental insurer
“And actually when we had raised the money, the original model was to be like a better type of dental insurance, but we were actually going to be an insurer.”
Miles Beckett Apr 29, 2026 ▶ 9:12
Assertion Partly supported
Flossy raised a $15M Series A round in spring 2022
“And then we raised a series A. I don't remember exactly when that was. I think it was in spring of 22. Right before the market crashed, and we raised, I don't remember the exact amount, but, you know, call it, fifteen million or so from that.”
Miles Beckett Apr 29, 2026 ▶ 9:48
Disclosure
Beckett borrowed $500K from acquirer Everyday Health to close the deal
“When we sold to Everyday Health, we had to borrow 500,000 dollars from them, so we didn't run out of cash, and we could actually close the transaction.”
Miles Beckett Apr 29, 2026 ▶ 10:51
Assertion Partly supported
Beckett: Everyday Health acquired Equal for around $30 million
“It was around thirty million dollars.”
Miles Beckett Apr 29, 2026 ▶ 11:50
Assertion Not checkable as stated
All Equal investors made at least a 2X return upon exit
“We had some, we had a, some investors at 10 X their money, everybody made two X or more.”
Miles Beckett Apr 29, 2026 ▶ 11:59
Assertion Not checkable as stated
Every company Beckett founded has delivered net positive investor returns
“Every, every, so, you know, knock, knock on wood, every company so far has been a net positive for investors, and some, you know, better multiples than other, and everybody's done well on the team.”
Miles Beckett Apr 29, 2026 ▶ 12:16
Assertion Partly supported
Silversheet achieved a larger exit than Equal despite lower revenue
“Equal, which we sold to Everyday Health, was quite a bit bigger in revenue than Silver Sheet, which we sold to AMN Healthcare, but the Silver Sheet was a much bigger exit.”
Miles Beckett Apr 29, 2026 ▶ 12:34
Disclosure
Flossy laid off about 30 employees in a 2024 restructuring
“About 30, I think.”
Miles Beckett Apr 29, 2026 ▶ 13:23
Disclosure
Flossy headcount rebounded to the mid-twenties after dropping to eight
“We're about mid-twenties, but we were, we got down to about eight.”
Miles Beckett Apr 29, 2026 ▶ 13:26
Assertion Not checkable as stated
Flossy is growing 60% to 70% month-over-month since launch
“We're, and again, we're growing like, you know, we're growing like 60, 70% month over month since launch.”
Miles Beckett Apr 29, 2026 ▶ 14:13
Assertion Not checkable as stated
Flossy adds $50,000 to $100,000 in net new ARR monthly
“Yeah, it's actually, in some months, it's been more than that, yeah. I mean, it's accelerating. It's growing very, very, very fast.”
Miles Beckett Apr 29, 2026 ▶ 14:58
Opinion
Beckett: Brex's $5B exit is a great outcome despite $12B peak
“The Brex outcome was a great outcome. Like the reality is that was a great outcome. That was a win. They sold a company for five billion dollars in like eight or 10 years. They crushed it. You know, it's not their fault that they raised a twelve billion dollar…”
Miles Beckett Apr 29, 2026 ▶ 15:37
Prediction Not checkable as stated
Beckett: Almost all peak 2020-2021 venture investors will not do well
“Almost everybody who invested in 20, 20, 21 at the peak is not going to do well. That's just the reality.”
Miles Beckett Apr 29, 2026 ▶ 15:57
Prediction Not checkable as stated
Beckett predicts Flossy will win the dental market by year-end
“I mean, I think we are rapidly becoming the dominant platform in dental And I think we will be, I think by the end of this year, it'll be clear that we've, you know, won in dental.”
Miles Beckett Apr 29, 2026 ▶ 16:33
Made with StarZero

Turn any episode into a week of clips.

This entire site, over 2,600 episodes transcribed, diarized, checked and made playable, runs on the StarZero media pipeline. Drop in your own episode and the podcast clipper finds the moments worth sharing, cuts them, captions them, and reframes them for every feed.